Paralel Advisors LLC Acquires Shares of 66,500 Omega Healthcare Investors, Inc. $OHI

Paralel Advisors LLC acquired a new position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) during the 2nd quarter, according to its most recent 13F filing with the SEC. The fund acquired 66,500 shares of the real estate investment trust’s stock, valued at approximately $3,171,000.

Other institutional investors also recently made changes to their positions in the company. BNP Paribas Financial Markets grew its holdings in Omega Healthcare Investors by 91.9% during the 4th quarter. BNP Paribas Financial Markets now owns 389,305 shares of the real estate investment trust’s stock worth $17,262,000 after acquiring an additional 186,399 shares in the last quarter. BOKF NA increased its position in shares of Omega Healthcare Investors by 51.8% in the 4th quarter. BOKF NA now owns 189,095 shares of the real estate investment trust’s stock worth $8,384,000 after purchasing an additional 64,539 shares during the last quarter. Oxbow Advisors LLC acquired a new stake in shares of Omega Healthcare Investors in the 1st quarter valued at about $7,373,000. Geode Capital Management LLC raised its stake in shares of Omega Healthcare Investors by 9.4% in the 4th quarter. Geode Capital Management LLC now owns 8,515,924 shares of the real estate investment trust’s stock valued at $377,648,000 after purchasing an additional 734,774 shares in the last quarter. Finally, Legal & General Group Plc lifted its position in shares of Omega Healthcare Investors by 12.2% during the fourth quarter. Legal & General Group Plc now owns 1,996,204 shares of the real estate investment trust’s stock worth $88,512,000 after purchasing an additional 216,856 shares during the last quarter. 65.25% of the stock is owned by institutional investors and hedge funds.

Omega Healthcare Investors Stock Performance

Omega Healthcare Investors stock opened at $46.81 on Friday. The firm’s 50-day moving average is $48.16 and its 200-day moving average is $47.00. Omega Healthcare Investors, Inc. has a 1 year low of $39.26 and a 1 year high of $52.39. The company has a market cap of $14.18 billion, a P/E ratio of 16.72, a PEG ratio of 1.90 and a beta of 0.57.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $1.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.51 by $0.68. The business had revenue of $328.25 million during the quarter, compared to the consensus estimate of $266.97 million. Omega Healthcare Investors had a net margin of 66.96% and a return on equity of 15.76%. The company’s revenue for the quarter was up 16.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.77 EPS. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. As a group, sell-side analysts predict that Omega Healthcare Investors, Inc. will post 3.12 earnings per share for the current year.

Omega Healthcare Investors Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Monday, August 3rd were paid a $0.68 dividend. The ex-dividend date was Monday, August 3rd. This is an increase from Omega Healthcare Investors’s previous quarterly dividend of $0.67. This represents a $2.72 dividend on an annualized basis and a yield of 5.8%. Omega Healthcare Investors’s payout ratio is presently 97.14%.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Scotiabank decreased their price target on Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating for the company in a research note on Thursday, June 18th. Wells Fargo & Company upped their price objective on Omega Healthcare Investors from $47.00 to $49.00 and gave the company an “equal weight” rating in a research note on Monday, June 1st. UBS Group set a $47.00 target price on Omega Healthcare Investors in a report on Thursday, June 18th. Weiss Ratings upgraded Omega Healthcare Investors from a “buy (b)” rating to a “buy (b+)” rating in a research report on Tuesday, June 30th. Finally, Raymond James Financial started coverage on Omega Healthcare Investors in a research report on Tuesday, June 16th. They issued an “outperform” rating and a $50.00 target price for the company. Six analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $49.21.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.